A WSI analysis algorithm that we designed to segment and quantify microglial IBA1 immunoreactivity within 5-μm radii of Aβ plaque edges demonstrated higher microglial plaque engagement in the PRIME LTE Patient compared to a series of untreated HIGH AD patients (Fig. 3c). This evidence concerns the gene AIF1 and Alzheimer disease.